CISPLATIN ACCORD cisplatin 10 mg/10 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 10 mg/10 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 50 mg/50 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

FLUOROURACIL ACCORD fluorouracil 2500 mg/50 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 2500 mg/50 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

FLUOROURACIL ACCORD fluorouracil 5000 mg/100 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 5000 mg/100 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

FLUOROURACIL ACCORD fluorouracil 500 mg/10 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 500 mg/10 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

FLUOROURACIL ACCORD fluorouracil 1000 mg/20 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 1000 mg/20 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

FLUOROURACIL ACCORD fluorouracil 250 mg/5 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 250 mg/5 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.

BUSULFAN ACCORD busulfan 60 mg/10 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

busulfan accord busulfan 60 mg/10 ml concentrated injection vial

accord healthcare pty ltd - busulfan, quantity: 60 mg - injection, concentrated - excipient ingredients: macrogol 400; dimethylacetamide - busulfan accord is indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.

TOPOTECAN ACCORD topotecan (as hydrochloride) 1 mg/1 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

topotecan accord topotecan (as hydrochloride) 1 mg/1 ml concentrated injection vial

accord healthcare pty ltd - topotecan hydrochloride, quantity: 1.09 mg (equivalent: topotecan, qty 1 mg) - injection, concentrated - excipient ingredients: tartaric acid; hydrochloric acid; sodium hydroxide; water for injections - topotecan accord is indicated as single agent therapy for the treatment of patients with:,? small cell lung carcinoma after failure of first line chemotherapy.,? metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.,topotecan accord is indicated in combination with cisplatin for the treatment of patients with:,? histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy.

TOPOTECAN ACCORD topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

topotecan accord topotecan (as hydrochloride) 4 mg/4 ml concentrated injection vial

accord healthcare pty ltd - topotecan hydrochloride, quantity: 4.346 mg (equivalent: topotecan, qty 4 mg) - injection, concentrated - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections; tartaric acid - topotecan accord is indicated as single agent therapy for the treatment of patients with:,? small cell lung carcinoma after failure of first line chemotherapy.,? metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.,topotecan accord is indicated in combination with cisplatin for the treatment of patients with:,? histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy.